Published On: May 27th, 2010
Pfizer exec Martin Mackay is decamping for cross-Atlantic rival AstraZeneca, where he’ll be president of R&D, a new position, Dow Jones Newswires reports.
Mackay held the same title at Pfizer from 2007 to 2009, but in the wake of the company’s Wyeth acquisition, he split the top job …

View original post here:
London Calling: Pfizer’s Mackay to Head R&D at AstraZeneca
Loading...
Leave a comment




Did you know: